Assessment of Anti-Cytogenotoxic Effects of Quercetin in Animals Treated with Topotecan

被引:14
作者
Bakheet, Saleh A. [1 ]
机构
[1] King Saud Univ, Dept Pharmacol & Toxicol, Coll Pharm, Riyadh 11451, Saudi Arabia
关键词
TOPOISOMERASES-I CAMPTOTHECIN; INDUCED DNA-DAMAGE; BONE-MARROW-CELLS; PRIMARY OVARIAN; LUNG-CANCER; INHIBITORS; APOPTOSIS; ASSAY; GENOTOXICITY; GLUTATHIONE;
D O I
10.1155/2011/824597
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The present investigation was directed to study the possible chemoprotective activity of orally administered quercetin against topotecan- induced cyto- and genotoxicity towards mouse somatic cells in vivo. DNA strand breaks, micronuclei formation, and mitotic activity were undertaken in the current study as markers of cyto- and genotoxicity. Oxidative stress markers such as intracellular reactive oxygen species generation, lipid peroxidation, and reduced and oxidized glutathione were assessed in bone marrow as a possible mechanism underlying this amelioration. Quercetin was neither cytotoxic nor genotoxic in mice at doses tested. Pretreatment of mice with quercetin significantly reduced topotecan-induced genotoxicity and cytotoxicity in bone marrow cells, and these effects were dose dependent. Moreover, prior administration of quercetin ahead of topotecan challenge ameliorated oxidative stress markers. In conclusion, quercetin has a protective role in the abatement of topotecan- induced cyto- and genotoxicity in the bone marrow cells of mice that resides, at least in part, on its antioxidant effects. Based on the data presented, strategies can be developed to decrease the topotecan-induced bone marrow suppression and secondary malignancy in cancer patients and medical personnel exposing to topotecan.
引用
收藏
页数:8
相关论文
共 41 条
[1]   The effect of quercetin on topotecan cytotoxicity in MCF-7 and MDA-MB 231 human breast cancer cells [J].
Akbas, SH ;
Timur, M ;
Ozben, T .
JOURNAL OF SURGICAL RESEARCH, 2005, 125 (01) :49-55
[2]  
ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548
[3]   Hematologic safety and tolerability of topotecan in recurrent ovarian cancer and small cell lung cancer: An integrated analysis [J].
Armstrong, DK ;
Spriggs, D ;
Levin, J ;
Poulin, R ;
Lane, S .
ONCOLOGIST, 2005, 10 (09) :686-694
[4]   Abatement by naringin of lomefloxacin-induced genomic instability in mice [J].
Attia, Sabry M. .
MUTAGENESIS, 2008, 23 (06) :515-521
[5]   The genotoxic and cytotoxic effects of nicotine in the mouse bone marrow [J].
Attia, Sabry M. .
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 2007, 632 (1-2) :29-36
[6]   Proanthocyanidins produce significant attenuation of doxorubicin-induced mutagenicity via suppression of oxidative stress [J].
Attia, Sabry M. ;
Bakheet, Saleh A. ;
Al-Rasheed, Nouf M. .
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2010, 3 (06) :404-413
[7]   The impact of quercetin on cisplatin-induced clastogenesis and apoptosis in murine marrow cells [J].
Attia, Sabry M. .
MUTAGENESIS, 2010, 25 (03) :281-288
[8]   Molecular Cytogenetic Evaluation of the Mechanism of Micronuclei Formation Induced by Camptothecin, Topotecan, and Irinotecan [J].
Attia, Sabry M. ;
Aleisa, Abdulaziz M. ;
Bakheet, Saleh A. ;
Al-Yahya, Abdulaziz A. ;
Al-Rejaie, Salim S. ;
Ashour, Abdelkader E. ;
Al-Shabanah, Othman A. .
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2009, 50 (02) :145-151
[9]   Genotoxicity of two anticancer drugs, gemcitabine and topotecan, in mouse bone marrow in vivo [J].
Aydemir, N ;
Bilaloglu, R .
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 2003, 537 (01) :43-51
[10]   GENOTOXICITY OF INHIBITORS OF DNA TOPOISOMERASES-I (CAMPTOTHECIN) AND TOPOISOMERASES-II (M-AMSA) INVIVO AND INVITRO [J].
BACKER, LC ;
ALLEN, JW ;
HARRINGTONBROCK, K ;
CAMPBELL, JA ;
DEMARINI, DM ;
DOERR, CL ;
HOWARD, DR ;
KLIGERMAN, AD ;
MOORE, MM .
MUTAGENESIS, 1990, 5 (06) :541-547